SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by InterOcean Capital Group LLC

InterOcean Capital Group LLC lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 63,931 shares of the exchange traded fund’s stock after selling 236 shares during the quarter. InterOcean Capital Group LLC’s holdings in SPDR S&P Biotech ETF were worth $5,708,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of XBI. Wealthfront Advisers LLC raised its holdings in shares of SPDR S&P Biotech ETF by 23.0% during the third quarter. Wealthfront Advisers LLC now owns 9,262 shares of the exchange traded fund’s stock worth $676,000 after purchasing an additional 1,733 shares during the last quarter. Compass Ion Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $248,000. Private Advisor Group LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 96.1% in the 3rd quarter. Private Advisor Group LLC now owns 141,583 shares of the exchange traded fund’s stock valued at $10,338,000 after buying an additional 69,390 shares during the period. Signaturefd LLC boosted its stake in shares of SPDR S&P Biotech ETF by 91.1% in the third quarter. Signaturefd LLC now owns 2,148 shares of the exchange traded fund’s stock worth $157,000 after buying an additional 1,024 shares during the last quarter. Finally, United Capital Management of KS Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 2.1% in the third quarter. United Capital Management of KS Inc. now owns 102,217 shares of the exchange traded fund’s stock worth $7,464,000 after buying an additional 2,081 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock traded up $1.17 during trading on Wednesday, hitting $92.74. 4,163,999 shares of the company traded hands, compared to its average volume of 11,268,915. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The company has a market cap of $7.07 billion, a PE ratio of 11.47 and a beta of 1.11. The stock’s 50-day simple moving average is $89.98 and its 200 day simple moving average is $87.46.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.